Co‐formulated abacavir‐lamivudine‐zidovudine for initial treatment of HIV infection and AIDS Edited (no change to conclusions)
Co‐formulated abacavir‐lamivudine‐zidovudine for initial treatment of HIV infection and AIDS Edited (no change to conclusions) is a topic covered in the Cochrane Abstracts.
To view the entire topic, please log in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
There's more to see -- the rest of this entry is available only to subscribers.
Citation
"Co‐formulated Abacavir‐lamivudine‐zidovudine for Initial Treatment of HIV Infection and AIDS Edited (no Change to Conclusions)." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/431985/all/Co���formulated_abacavir���lamivudine���zidovudine_for_initial_treatment_of_HIV_infection_and_AIDS_Edited__no_change_to_conclusions_. Accessed 19 May 2022.
Co‐formulated abacavir‐lamivudine‐zidovudine for initial treatment of HIV infection and AIDS Edited (no change to conclusions). Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431985/all/Co���formulated_abacavir���lamivudine���zidovudine_for_initial_treatment_of_HIV_infection_and_AIDS_Edited__no_change_to_conclusions_. Accessed May 19, 2022.
Co‐formulated abacavir‐lamivudine‐zidovudine for initial treatment of HIV infection and AIDS Edited (no change to conclusions). In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/431985/all/Co���formulated_abacavir���lamivudine���zidovudine_for_initial_treatment_of_HIV_infection_and_AIDS_Edited__no_change_to_conclusions_
Co‐formulated Abacavir‐lamivudine‐zidovudine for Initial Treatment of HIV Infection and AIDS Edited (no Change to Conclusions) [Internet]. In: Cochrane Abstracts. [cited 2022 May 19]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/431985/all/Co���formulated_abacavir���lamivudine���zidovudine_for_initial_treatment_of_HIV_infection_and_AIDS_Edited__no_change_to_conclusions_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Co‐formulated abacavir‐lamivudine‐zidovudine for initial treatment of HIV infection and AIDS Edited (no change to conclusions)
ID - 431985
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/431985/all/Co���formulated_abacavir���lamivudine���zidovudine_for_initial_treatment_of_HIV_infection_and_AIDS_Edited__no_change_to_conclusions_
DB - Evidence Central
DP - Unbound Medicine
ER -